ArticleInsights into imaging2025
Using optimized CT type to predict histological classifications of thymic epithelial tumors: a radiomics integrated analysis.
Article in Insights into imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- CT Histogram Analysis for Predicting Malignancy in Anterior Mediastinal Masses.Thoracic research and practice · 2026Article
- An interpretable machine learning approach using nnU-Net-based radiomics for preoperative risk stratification of thymic epithelial tumors: a multicenter study.BMC medical imaging · 2026Article
- Advanced thymic epithelial tumours after neoadjuvant therapy: a narrative review of surgical challenges and strategies.Mediastinum (Hong Kong, China) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectiveTo develop and externally validate an integrated model that utilizes optimized radiomics features from non-contrast-enhanced CT (NE-CT) or contrast-enhanced CT (CE-CT), along with morphological features and clinical risk factors, to predict histological classifications of thymic epithelial tumors (TETs).
methodsA total of 182 patients with TET, classified as the low-risk group and the high-risk group based on histology, were divided into a training cohort (N = 122, center 1) and an external validation cohort (N = 60, center 2). Radiomics features were extracted from different CT types, followed by feature selection, including consistency, correlation, and importance tests, to generate Rad-scores for both NE-CT and CE-CT. The integrated model was developed by combining the optimal Rad-score, morphological features, and clinical risk factors using multivariate logistic regression. Model performance was assessed by the area under the receiver operating characteristic curve (AUC) and compared by Delong test. A nomogram was used to visually present the integrated model.
resultsA total of 851 radiomics features were extracted, with NE-CT and CE-CT Rad-scores consisting of four and five features, respectively. The AUCs of the CE-CT Rad-score were higher than those of the NE-CT Rad-score in both the training cohort (0.783 vs 0.749) and the external validation cohort (0.775 vs 0.723, p = 0.361). The integrated model, combining five morphological features and the CE-CT Rad-score, achieved AUCs of 0.814 and 0.802 in the training and external validation cohorts, respectively.
conclusionThe integrated model, incorporating radiomics features from CE-CT and morphological features, can help to identify the histological classifications of TETs. CRITICAL RELEVANCE STATEMENT: This study developed an integrated model based on radiomics features from contrast-enhanced CT and morphological features, demonstrating that the integrated model has impressive predictive capability in distinguishing histological classifications of thymic epithelial tumors through external validation. KEY POINTS: Radiomics features extracted from CT more effectively represented thymic epithelial tumor (TET) heterogeneity than morphological features. The radiomics model using contrast-enhanced CT outperformed that using non-contrast-enhanced CT in identifying histological classifications of TET. The integrated model, combining radiomics and morphological features, exhibited the highest performance in predicting TET histological classifications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.